American Oncology Network to Host Investor Presentation Webcast on September 29
September 27 2023 - 4:05PM
American Oncology Network, Inc. (“AON” or the “Company”)
(Nasdaq: AONC), a rapidly growing network of community-based
oncology practices announced today that it will host an investor
presentation webcast on Friday, September 29, 2023 at 8:00 am
Eastern Time, with its Chief Executive Officer, Todd Schonherz and
Chief Financial Officer, David Gould. During the presentation,
management will walk through AON’s business model, growth strategy,
and unique value proposition.
The Company recently completed its business combination with
Digital Transformation Opportunities Corp., a special purpose
acquisition company focused on the healthcare industry, on
September 20, 2023, and the combined company commenced trading on
the Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol
“AONC” on September 21, 2023.
Webcast Information:
Time: Friday, September 29, 2023, at 8:00 a.m. Eastern Time
Webcast Registration Link:
https://viavid.webcasts.com/starthere.jsp?ei=1636083&tp_key=3eab331b7f
An archived replay of the presentation will be available on the
American Oncology Network’s Investor Relations website at
https://investors.aoncology.com.
About American Oncology Network
The American Oncology Network (AON) (Nasdaq: AONC) is an
alliance of physicians and seasoned healthcare leaders partnering
to ensure the long-term success of community oncology and other
specialties. Launched in 2018, the rapidly expanding AON network
represents 109 physicians and 86 nurse practitioners and physician
assistants practicing across 19 states. The executive management
team of AON encompasses more than four decades of oncology practice
management experience, enabling physicians to focus on what matters
most — providing the highest quality care for patients. Learn more
at www.aoncology.com.
Forward-Looking Statements
Certain statements in this press release are forward-looking
statements. Forward-looking statements generally relate to future
events including future financial or operating performance of
American Oncology Network, Inc. (“New AON”). Forward-looking
statements generally relate to future events or New AON’s future
financial or operating performance. For example, projections of
future revenue and other metrics are forward-looking statements. In
some cases, you can identify forward-looking statements by
terminology such as “may”, “should”, “expect”, “intend”, “will”,
“estimate”, “anticipate”, “believe”, “predict”, “potential” or
“continue”, or the negatives of these terms or variations of them
or similar terminology. Such forward-looking statements are subject
to risks, uncertainties, and other factors that could cause actual
results to differ materially from those expressed or implied by
such forward-looking statements.
These forward-looking statements are based upon estimates and
assumptions that, while considered reasonable by New AON and its
management, are inherently uncertain and are inherently subject to
risks, variability and contingencies, many of which are beyond New
AON’s control. Factors that may cause actual results to differ
materially from current expectations include, but are not limited
to: (1) the ability to recognize the anticipated benefits of the
Business Combination, which may be affected by, among other things,
competition, the ability of the combined company to grow and manage
growth profitably, maintain key relationships and retain its
management and key employees; (2) costs related to the Business
Combination; (3) changes in applicable laws or regulations; (4) the
possibility that New AON may be adversely affected by other
economic, business, and/or competitive factors; (5) New AON’s
estimates of expenses and profitability; and (6) other risks and
uncertainties set forth in the section entitled “Risk Factors” and
“Cautionary Note Regarding Forward-Looking Statements” in New AON’s
final prospectus relating to the Business Combination dated July
18, 2023 filed with the SEC, and in subsequent filings with the
SEC. New AON cautions that the foregoing list of factors is not
exclusive or exhaustive and investors should not place undue
reliance upon any forward-looking statements, including
projections, which speak only as of the date made. If any of these
risks materialize or New AON’s assumptions prove incorrect, actual
results could differ materially from the results implied by these
forward-looking statements. There may be additional risks that New
AON does not presently know or that New AON currently believes are
immaterial that could also cause actual results to differ from
those contained in the forward-looking statements. In addition,
forward-looking statements reflect New AON’s expectations, plans or
forecasts of future events and views as of the date of this
communication. New AON anticipates that subsequent events and
developments will cause New AON’s assessments to change. However,
while New AON may elect to update these forward-looking statements
at some point in the future, New AON specifically disclaims any
obligation to do so, unless required by applicable law. These
forward-looking statements should not be relied upon as
representing New AON’s assessments as of any date subsequent to the
date of this communication. New AON does not give any assurance
that New AON will achieve its expectations. Accordingly, undue
reliance should not be placed upon the forward-looking
statements.
Investor Contact:David Gould, Chief Financial
OfficerDavid.Gould@aoncology.com
American Oncology Network (NASDAQ:AONC)
Historical Stock Chart
From Apr 2024 to May 2024
American Oncology Network (NASDAQ:AONC)
Historical Stock Chart
From May 2023 to May 2024